APA

Krishnaswamy A., Lincoff A. M., . (20110808). Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux. : Evidence-based medicine.

Chicago

Krishnaswamy Amar, Lincoff A Michael, . 20110808. Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux. : Evidence-based medicine.

Harvard

Krishnaswamy A., Lincoff A. M., . (20110808). Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux. : Evidence-based medicine.

MLA

Krishnaswamy Amar, Lincoff A Michael, . Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux. : Evidence-based medicine. 20110808.